- Category
CP Reports Store
Welcome to the home of CP Reports, we are the only publisher of life science deal term reports in the industry.
CP Reports Store offers over 100 report titles that focus upon different deal types and technology or therapy areas including licensing, collaborative R&D, co-promotion, biomarkers, diagnostics, oncology, immunology all of which provide a detailed insight into the latest life science deal making trends.
Browse our reports by type to find your ideal match.
- Deal type reports
- Industry sector reports
- Stage partnered reports
- Technology reports
- Therapy reports
Our reports are updated regularly and include full coverage of the latest deals in the chosen report type.
Unsure which report to select? Contact our report analysts who will assist your decision.
-
Vaccine Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Cancer Diagnostic Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Cancer Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Infectious Vaccine Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Diagnostic Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Drug Delivery Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Drug Delivery Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Antibody Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Antibiotic Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Antibiotic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Companion Diagnostic Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Companion Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More -
Precision Medicine Collaboration and Licensing Deals 2016-2023November 2023$3,995.00
Precision Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023
Learn More